A Phase I/II Trial of the Combination of Azacitidine and Gemtuzumab Ozogamicin for Treatment of Relapsed Acute Myeloid Leukemia
Keywords: آزمایشات بالینی مرحله دوم; AML; Antibody-drug conjugate; Hypomethylating agents; Phase I clinical trials; Phase II clinical trials;